Actively Recruiting
Study to Evaluate Vagitab-T Vaginal Tablets with Metronidazole for Treating and Preventing Recurrence of Bacterial Vaginosis in Women Aged 18 to 65
Led by S.I.I.T. Srl · Updated on 2025-05-28
30
Participants Needed
1
Research Sites
1 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the vaginal administration of Vagitab-T, a medical device already available in parts of Europe, to see how well it works and how safe it is for women with bacterial vaginosis BV. BV is a common condition affecting 20-25% of women, often recurring multiple times a year. This study focuses on reducing the recurrence rate of BV, improving vaginal fluidity and microflora balance during antibiotic treatment, and assessing participants quality of life and safety perceptions over a 3-month period. All 30 women in the study will receive Vagitab-T vaginal tablets for three monthly cycles of 10 days each, alongside a standard 7-day course of metronidazole antibiotic treatment taken either vaginally or orally. Vagitab-T contains probiotic L. plantarum HA-119 and other components aimed at restoring healthy vaginal flora without disrupting normal cell functions. There is no comparison group, and the study will last 90 days for each participant. Participants will visit the clinic at the start and end of the study, with phone calls during each treatment cycle to monitor progress. Researchers will evaluate recurrence of BV, vaginal secretion fluidity, vaginal flora normality, symptoms like burning and discharge, and overall safety and quality of life. The study includes safety assessments and tracks adverse effects throughout the 90-day follow-up period.
CONDITIONS
Brief Title
Evaluation of the Medical Device Vagitab - T as Adjuvant Therapy in Patients With Bacterial Vaginosis.
Research Team
F
Francesca Montarolo, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here